BioCentury
ARTICLE | Distillery Therapeutics

Other

March 8, 2017 6:33 PM UTC

Cell culture and mouse studies suggest a synthetic glycolipid adjuvant could help improve the efficacy of vaccines for infectious diseases with less toxicity than conventional adjuvants. In human mono...